Curcumin in Advanced Cervical Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Determine the efficacy and safety of turmeric in the treatment of patients with advanced cervical cancer. Efficacy will be determined through radiological and histopathological criteria through the rate of response to treatment, duration of response, the rate of objective response and disease control, as well as overall survival and disease-free survival. The safety of therapy will be evaluated according to the Common Terminology Criteria for Adverse Events (CTCAE) classification
Epistemonikos ID: 10dd86851813ba7d6a0ce1d3d145d20789ea8d40
First added on: May 07, 2024